Correction to: Pexidartinib: First Approval

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1950
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Correction to: Pexidartinib: First Approval ; volume:80 ; number:4 ; day:28 ; month:2 ; year:2020 ; pages:447 ; date:3.2020
Drugs ; 80, Heft 4 (28.2.2020), 447, 3.2020

Urheber
Lamb, Yvette N.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40265-020-01280-5
URN
urn:nbn:de:101:1-2020052519444087121235
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lamb, Yvette N.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: Lonafarnib: First Approval

Correction to: Lonafarnib: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Nedosiran: First Approval

Correction to: Nedosiran: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Ritlecitinib: First Approval

Correction to: Ritlecitinib: First Approval

Correction to: Zavegepant: First Approval

Correction to: Zavegepant: First Approval

Correction to: Filgotinib: First Approval

Correction to: Filgotinib: First Approval

Correction to: Sotorasib: First Approval

Correction to: Sotorasib: First Approval

Correction to: Inclisiran: First Approval

Correction to: Inclisiran: First Approval

Correction to: Tralokinumab: First Approval

Correction to: Tralokinumab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Ubrogepant: First Approval

Correction to: Ubrogepant: First Approval

Verbundene Objekte